NASDAQ:QDEL - Quidel Stock Price, News & Analysis

Quidel trades on the NASDAQ under the ticker symbol "QDEL."

Quidel Co. (NASDAQ:QDEL) released its quarterly earnings data on Thursday, August, 8th. The company reported $0.36 EPS for the quarter, beating analysts' consensus estimates of $0.34 by $0.02. The business had revenue of $108.25 million for the quarter, compared to the consensus estimate of $108.40 million. Quidel had a return on equity of 23.34% and a net margin of 13.71%. The business's revenue for the quarter was up 4.9% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.36 EPS. View Quidel's Earnings History.

Quidel is scheduled to release their next quarterly earnings announcement on Tuesday, November 5th 2019. View Earnings Estimates for Quidel.

4 brokerages have issued 12 month price targets for Quidel's shares. Their predictions range from $63.00 to $77.00. On average, they anticipate Quidel's stock price to reach $71.00 in the next year. This suggests a possible upside of 21.7% from the stock's current price. View Analyst Price Targets for Quidel.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Quidel in the last year. There are currently 1 hold rating, 2 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Quidel.

Headlines about QDEL stock have trended positive on Sunday, according to InfoTrie Sentiment. The research group rates the sentiment of media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Quidel earned a news impact score of 2.5 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 6.0 out of 10, indicating that recent media coverage is somewhat likely to have an effect on the company's share price in the immediate future. View News Stories for Quidel.

Some companies that are related to Quidel include IPSEN S A/S (IPSEY), Neogen (NEOG), Immunomedics (IMMU), Myriad Genetics (MYGN), Lantheus (LNTH), Intellia Therapeutics (NTLA), Quotient (QTNT), Heska (HSKA), Meridian Bioscience (VIVO), Oxford Immunotec Global (OXFD), Palatin Technologies (PTN), Nymox Pharmaceutical (NYMX), Vermillion (VRML), ImmuCell (ICCC) and Celldex Therapeutics (CLDX).

Based on aggregate information from My MarketBeat watchlists, some companies that other Quidel investors own include Netflix (NFLX), Adobe (ADBE), Intel (INTC), NVIDIA (NVDA), Alibaba Group (BABA), Mastercard (MA), Advanced Micro Devices (AMD), Square (SQ), Visa (V) and Cisco Systems (CSCO).

Quidel's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Price T Rowe Associates Inc. MD (15.74%), Brown Capital Management LLC (14.18%), Vanguard Group Inc. (8.67%), BlackRock Inc. (5.94%), Oracle Investment Management Inc. (4.31%) and Eagle Asset Management Inc. (1.60%). Company insiders that own Quidel stock include Charles P Slacik, Douglas C Bryant, Edward Keith Russell, Jack W Schuler, Karen Gibson, Kenneth F Buechler, Mary Lake Ph D Polan, Michael Donald Jr Abney, Randall J Steward, Ratan S Borkar, Robert Joseph Bujarski, Thomas D Brown and Werner Kroll. View Institutional Ownership Trends for Quidel.

QDEL stock was sold by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Renaissance Technologies LLC, Price T Rowe Associates Inc. MD, Oracle Investment Management Inc., D. E. Shaw & Co. Inc., Mackenzie Financial Corp, Mackenzie Financial Corp and SG Americas Securities LLC. Company insiders that have sold Quidel company stock in the last year include Charles P Slacik, Douglas C Bryant, Edward Keith Russell, Karen Gibson, Kenneth F Buechler, Mary Lake Ph D Polan, Michael Donald Jr Abney, Randall J Steward, Ratan S Borkar, Robert Joseph Bujarski and Thomas D Brown. View Insider Buying and Selling for Quidel.

QDEL stock was purchased by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Invesco Ltd., Brown Capital Management LLC, Nuveen Asset Management LLC, BlackRock Inc., Marshall Wace North America L.P., Man Group plc and Chicago Equity Partners LLC. View Insider Buying and Selling for Quidel.

Shares of QDEL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of QDEL stock can currently be purchased for approximately $58.34.

Quidel has a market capitalization of $2.42 billion and generates $522.28 million in revenue each year. The company earns $74.18 million in net income (profit) each year or $2.82 on an earnings per share basis. Quidel employs 1,224 workers across the globe.View Additional Information About Quidel.

The official website for Quidel is http://www.quidel.com/.

Quidel's mailing address is 12544 HIGH BLUFF DRIVE SUITE 200, SAN DIEGO CA, 92130. The company can be reached via phone at 858-552-1100 or via email at [email protected]